Increased Tbx1 expression may play a role via TGFβ-Smad2/3 signaling pathway in acute kidney injury induced by gentamicin.

Hongkun Jiang, Lei Li, Jesse Li‐Ling, Guangrong Qiu, Zhibin Niu, Yunpeng Li, Yaoguo Huang, Kailai SunPubMed 2014

TL;DR

This study investigates the role of the T-box 1 (Tbx1) gene in gentamicin-induced acute kidney injury (AKI) in rats. They found that increased Tbx1 expression in injured kidneys activates the pro-apoptotic TGF-β-Smad2/3 pathway while suppressing the protective Smad1/5/8 pathway, suggesting Tbx1 could be a biomarker and therapeutic target for AKI.

What Problem Does This Paper Address?

Gentamicin (GM) is a widely used antibiotic, but it can cause nephrotoxicity, leading to acute kidney injury (AKI) in a significant percentage of patients. While AKI is a serious clinical concern, the precise molecular mechanisms underlying GM-induced kidney damage are not fully understood. Specifically, the role of transcription factors involved in embryonic kidney development, such as T-box 1 (Tbx1), in the context of AKI has not been explored. This paper aims to bridge this knowledge gap by investigating the involvement of Tbx1 and its associated signaling pathways in GM-induced AKI.

Methods

The researchers utilized a rat model of AKI induced by gentamicin injections. They employed a multi-pronged approach to assess Tbx1's role:

  • Gene and Protein Expression Analysis: Real-time RT-PCR and Western blotting were used to quantify the expression levels of Tbx1, TGF-β, phosphorylated Smad2/3 (p-Smad2/3), and phosphorylated Smad1/5/8 (p-Smad1/5/8) in kidney tissues at various time points after GM administration.
  • Apoptosis Assessment: Terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay was performed to detect apoptotic renal cells. Additionally, the expression of apoptosis-related genes, caspase-3 (pro-apoptotic) and Bcl-2 (anti-apoptotic), was measured.
  • Histopathology: Hematoxylin and eosin (HE) staining was used to examine structural changes and tubular injury in kidney tissues.
  • Immunohistochemistry and Immunofluorescence: These techniques were used to visualize the localization of Tbx1 protein within the kidney tissues.
  • In Vitro Knockdown Studies: Rat renal tubular cells (NRK cells) were transfected with Tbx1-specific small interfering RNA (siRNA) to reduce Tbx1 expression. The effects of Tbx1 knockdown on the TGF-β-Smad signaling pathway were then analyzed using real-time RT-PCR and Western blotting.
  • Statistical Analysis: Spearman correlation was used to assess the relationship between Tbx1 expression and apoptosis. One-way ANOVA and t-tests were employed for group comparisons.

Datasets

Not discussed in the paper. The study utilized experimental data generated from rat models and cell cultures.

Key Insights and Ideas

  • Tbx1 as a Player in AKI: The study strongly suggests that Tbx1, a gene typically associated with embryonic development, is actively involved in the kidney's response to injury induced by gentamicin. Its expression significantly increases in damaged kidneys.
  • TGF-β-Smad2/3 Pathway Activation: Increased Tbx1 expression appears to directly trigger the TGF-β-Smad2/3 signaling pathway, which is known to promote apoptosis and fibrosis in the kidney. This is a crucial link, as this pathway is implicated in various kidney diseases.
  • Smad1/5/8 Pathway Inhibition: Conversely, Tbx1 activation seems to suppress the Smad1/5/8 pathway, which is generally considered protective and involved in kidney repair. This dual action of Tbx1—activating one pathway while inhibiting another—highlights its complex regulatory role.
  • Apoptosis Link: The heightened expression of Tbx1 directly correlates with an increase in apoptotic renal cells, as evidenced by TUNEL staining and changes in caspase-3 and Bcl-2 levels. This suggests Tbx1 contributes to cell death in AKI.
  • Therapeutic Potential: The findings position Tbx1 as a potential biomarker for AKI and suggest that targeting Tbx1 or its downstream pathways could offer novel therapeutic strategies for treating gentamicin-induced nephropathy.

Key Results

  • Tbx1 Upregulation: Tbx1 mRNA and protein levels were significantly increased in GM-treated rat kidneys, peaking around day 7 post-injury and returning to baseline by day 21.
  • TGF-β and p-Smad2/3 Increase: Levels of TGF-β mRNA and p-Smad2/3 protein were elevated in GM-induced AKI, showing a strong positive correlation with Tbx1 expression.
  • p-Smad1/5/8 Decrease: In contrast, p-Smad1/5/8 protein levels were reduced in injured kidneys, exhibiting a strong negative correlation with Tbx1 expression.
  • Tbx1 Knockdown Effects: In NRK cells, silencing Tbx1 led to decreased TGF-β and p-Smad2/3 levels, and increased p-Smad1/5/8 levels, confirming Tbx1's role in regulating these pathways.
  • Increased Apoptosis: GM-treated kidneys showed a significant increase in TUNEL-positive cells, indicating apoptosis. This increase strongly correlated with Tbx1 mRNA levels.
  • Caspase-3 and Bcl-2 Changes: Caspase-3 expression was markedly increased, while Bcl-2 expression was decreased in GM-induced AKI kidneys, further supporting the role of apoptosis.
  • Histological Damage: Histological analysis revealed tubular damage, degeneration, and necrosis in GM-treated kidneys, with the most severe injury observed around day 7.

Limitations and Future Work

  • Model Specificity: The study was conducted in a rat model. Further research is needed to confirm these findings in other animal models and, importantly, in human AKI.
  • Mechanism of Tbx1 Regulation: While the study shows Tbx1's role in AKI, the upstream mechanisms that lead to Tbx1 upregulation following gentamicin exposure are not fully elucidated.
  • Therapeutic Efficacy: The paper suggests Tbx1-blocking therapies as a potential treatment. Future work should focus on developing and testing specific inhibitors or modulators of Tbx1 activity in preclinical AKI models.
  • Broader Implications: Exploring Tbx1's role in other forms of AKI beyond gentamicin-induced injury would broaden the understanding of its general significance in kidney pathophysiology.

Summary updated

Abstract

T-box 1 (Tbx1) gene is closely involved in embryonic kidney development. To explore the role of Tbx1 in acute kidney injury (AKI) and the underlying mechanism, we detected the expression of Tbx1 and components of transforming growth factor-beta (TGF-β) signaling pathways including TGF-β, phosphorylated Smad2/3 (p-Smad2/3) and phosphorylated Smad1/5/8 (p-Smad1/5/8) in kidney tissues derived from a rat model for AKI induced by gentamicin (GM). Apoptosis of renal cells was assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL), along with the expression of two essential genes involved in apoptosis, caspase-3 and Bcl-2. Correlation between Tbx1 expression and the number of TUNEL-positive cells was analyzed by a Spearman test. Expression of TGF-β, p-Smad2/3 and p-Smad1/5/8 in Tbx1-knockdown NRK cells was also analyzed by real-time RT-PCR and Western blotting. Markedly increased Tbx1 expression was found in the injured kidney tissues, which has activated the TGFβ-Smad2/3 pathway whilst suppressed Smad1/5/8 expression. Conversely, decreased TGF-β and p-Smad2/3 levels, and elevated p-Smad1/5/8 levels were detected in Tbx1-knockdown NRK cells. More apoptotic cells were detected in the injured kidneys, which has well correlated with the expression of Tbx1. Expression of caspase-3 was markedly increased, while Bcl-2 was decreased in the injured kidney tissues. Above findings suggested that activation of Tbx1 is involved in AKI through the TGFβ-Smad2/3 pathway. Tbx1 expression may therefore serve as a marker for AKI, and Tbx1-blocking therapies may provide an option for treating GM-induced nephropathy.
BibTeX
@inproceedings{jiang2014increased,
  author = {Hongkun Jiang and Lei Li and Jesse Li‐Ling and Guangrong Qiu and Zhibin Niu and Hong Jiang and Yunpeng Li and Yaoguo Huang and Kailai Sun},
  title = {{Increased Tbx1 expression may play a role via TGFβ-Smad2/3 signaling pathway in acute kidney injury induced by gentamicin.}},
  booktitle = {PubMed},
  year = {2014},
}
Figure